4.4 Review

European clinical practice guidelines on the use of chemotherapy for advanced oesophageal and gastric cancers: a critical review using the AGREE II and the AGREE-REX instruments

Related references

Note: Only part of the references are listed.
Review Oncology

European clinical practice guidelines on the use of chemotherapy for advanced oesophageal and gastric cancers: a critical review using the AGREE II and the AGREE-REX instruments

Marilina Santero et al.

Summary: This study aimed to assess the methodological quality of recent clinical practice guidelines for advanced oesophageal and gastric cancers in Europe and synthesize their recommendations on chemotherapy. The results showed deficiencies in the applicability domain of most guidelines, and a lack of consideration for patient views and preferences in some guidelines.

CLINICAL & TRANSLATIONAL ONCOLOGY (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews

M. Santero et al.

Summary: This paper provides an overview of 16 systematic reviews on the effectiveness of systemic oncological treatments (SOT) in patients with advanced esophageal or gastric cancers, with most reviews having low methodological quality and high overlap of primary studies, leading to uncertainty about whether SOT can improve overall survival and progression-free survival. High-quality systematic reviews and further randomized clinical trials are needed for a more thorough assessment of patient-centered outcomes.

BMC CANCER (2021)

Article Medicine, General & Internal

Development and Validation of a Tool to Assess the Quality of Clinical Practice Guideline Recommendations

Melissa C. Brouwers et al.

JAMA NETWORK OPEN (2020)

Review Health Care Sciences & Services

Systematic reviews of clinical practice guidelines: a methodological guide

Amy Johnston et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2019)

Review Health Care Sciences & Services

Incorporating patients' views in guideline development: a systematic review of guidance documents

Anna Selva et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2017)

Article Medicine, General & Internal

Evidence for overuse of medical services around the world

Shannon Brownlee et al.

LANCET (2017)

Article Oncology

SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016)

M. Martin-Richard et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2016)

Article Medicine, General & Internal

The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines

Melissa C. Brouwers et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Medicine, General & Internal

The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines

Melissa C. Brouwers et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Health Care Sciences & Services

The AGREE Enterprise: a decade of advancing clinical practice guidelines

Julie Makarski et al.

IMPLEMENTATION SCIENCE (2014)

Review Gastroenterology & Hepatology

Epidemiology of esophageal cancer

Yuwei Zhang

WORLD JOURNAL OF GASTROENTEROLOGY (2013)

Article Oncology

Oesophageal cancer survival in Europe: A EUROCARE-4 study

A. T. Gavin et al.

CANCER EPIDEMIOLOGY (2012)

Article Oncology

SEOM clinical guidelines for the diagnosis and treatment of gastric adenocarcinoma

Fernando Rivera et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2012)

Editorial Material Oncology

Why do our patients get chemotherapy until the end of life?

S. Braga

ANNALS OF ONCOLOGY (2011)

Article Oncology

SEOM clinical guidelines for the treatment of oesophageal cancer

Javier Gallego et al.

CLINICAL & TRANSLATIONAL ONCOLOGY (2011)

Review Gastroenterology & Hepatology

Guidelines for the management of oesophageal and gastric cancer

William H. Allum et al.

Editorial Material Health Care Sciences & Services

Appraising a tool for guideline appraisal (the AGREE II instrument)

Antonio L. Dans et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2010)

Review Health Care Sciences & Services

The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies

Pablo Alonso-Coello et al.

QUALITY & SAFETY IN HEALTH CARE (2010)

Review Gastroenterology & Hepatology

Epidemiology of gastric cancer

Katherine D. Crew et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2006)

Review Health Care Sciences & Services

A systematic review of appraisal tools for clinical practice guidelines: multiple similarities and one common deficit

J Vlayen et al.

INTERNATIONAL JOURNAL FOR QUALITY IN HEALTH CARE (2005)